Human Longevity and Performance Impact Venture Fund Investor
Human Longevity and Performance Impact Venture Fund is a longevity focused early stage venture capital fund.
Industry:
Omics-Based Biomarkers
Investment Stage:
Early Stage Venture
Investors Number:
2
Technology:
Biomarkers
Headquarters:
United States
Founded Date:
2020-01-01
Investor Type:
Venture Capital
Number Of Exists:
1
Employee Number:
1-10